Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of duvelisib and nivolumab for stage IIb–IVB mycosis fungoides and Sézary syndrome; trial status is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Duvelisib (duvelisib)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 | Phase 1 | Status: ACTIVE_NOT_RECRUITING